StockWatch
·

Tatva Chintan Pharma Chem Ltd Q4 FY25 Results

TATVAQ4 FY25 Results
Filing
MetricValue ( Cr)vs Q3 FY25
Revenue107.8625.6%
Total Income108.5926.4%
Expenditure106.5623.6%
PBT2.03962.5%
Net Profit1.03646.4%
OPM8.30%17.17pp
NPM0.95%0.79pp
EPS0.44633.3%
View full financials

Informational and educational content only. Not investment advice.